• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾队列中早产儿出生后生长及视网膜病变筛查标准的验证

Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria in a Taiwanese Cohort.

作者信息

Huang Ching-Wen, Yeh Po-Ting, Tsao Po-Nien, Chou Hung-Chieh, Chen Chien-Yi, Yen Ting-An, Huang Hsin-Chung, Lai Tso-Ting

机构信息

From the Department of Ophthalmology (C.-W.H., P.-T.Y., T.-T.L.), National Taiwan University Hospital, Taipei, Taiwan.

Department of Pediatrics (P.-N.T., H.-C.C., C.-Y.C., T.-A.Y., H.-C.H.), National Taiwan University Hospital, Taipei, Taiwan; Research Center for Developmental Biology & Regenerative Medicine (P.-N.T.), National Taiwan University, Taipei, Taiwan.

出版信息

Am J Ophthalmol. 2022 May;237:22-31. doi: 10.1016/j.ajo.2021.11.007. Epub 2021 Nov 13.

DOI:10.1016/j.ajo.2021.11.007
PMID:34780799
Abstract

PURPOSE

To validate the performance of Postnatal Growth and Retinopathy of Prematurity (G-ROP) screening criteria in a Taiwanese cohort.

DESIGN

Screening evaluation with retrospective data.

METHOD

Premature infants who underwent retinopathy of prematurity (ROP) screening between January 2015 and April 2019 at a tertiary hospital were examined. Infants with known final ROP results and complete longitudinal weight records were included. G-ROP screening criteria, both original and simplified (G-ROP 180 g), were applied as the prediction model for type 1 ROP; sensitivity and specificity were analyzed. The reduction in the number of infants requiring ROP screening and the number of funduscopic examinations were calculated.

RESULT

A total of 303 infants with documented ROP outcomes and complete weight gain records were examined. Of these, 103 infants developed ROP, of whom 29 developed type 1 ROP, whereas the other 200 did not develop ROP. For the detection of type 1 ROP, the sensitivity and specificity of the original G-ROP screening criteria were 96.6% and 42.3%, and 100% and 31%, for the simplified G-ROP 180 g model, respectively. The reduction in the number of infants requiring screening and funduscopic examinations was 32.6% and 33.5% for the original G-ROP criteria, and 28.1% and 23.2% for the G-ROP 180 g model, respectively.

CONCLUSION

Both the original G-ROP and G-ROP 180 g criteria attained high sensitivities in detecting type 1 ROP in the current Taiwanese cohort, with the G-ROP 180-g model outperforming the original one. Validation and modification may be required before applying G-ROP screening criteria to different populations.

摘要

目的

验证产后生长与早产儿视网膜病变(G-ROP)筛查标准在台湾队列中的表现。

设计

采用回顾性数据进行筛查评估。

方法

对2015年1月至2019年4月在一家三级医院接受早产儿视网膜病变(ROP)筛查的早产儿进行检查。纳入已知最终ROP结果且有完整纵向体重记录的婴儿。将原始和简化的(G-ROP 180 g)G-ROP筛查标准用作1型ROP的预测模型;分析敏感性和特异性。计算需要进行ROP筛查的婴儿数量和眼底检查次数的减少情况。

结果

共检查了303例有记录的ROP结果且有完整体重增加记录的婴儿。其中,103例婴儿发生了ROP,其中29例发生了1型ROP,而其他200例未发生ROP。对于1型ROP的检测,原始G-ROP筛查标准的敏感性和特异性分别为96.6%和42.3%,简化的G-ROP 180 g模型分别为100%和31%。原始G-ROP标准需要筛查的婴儿数量和眼底检查次数的减少分别为32.6%和33.5%,G-ROP 180 g模型分别为28.1%和23.2%。

结论

原始G-ROP和G-ROP 180 g标准在当前台湾队列中检测1型ROP时均具有较高的敏感性,G-ROP 180 g模型优于原始模型。在将G-ROP筛查标准应用于不同人群之前,可能需要进行验证和修改。

相似文献

1
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria in a Taiwanese Cohort.台湾队列中早产儿出生后生长及视网膜病变筛查标准的验证
Am J Ophthalmol. 2022 May;237:22-31. doi: 10.1016/j.ajo.2021.11.007. Epub 2021 Nov 13.
2
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.早产儿视网膜病变改良筛查标准的制定:来自早产儿出生后生长和早产儿视网膜病变研究的初步结果。
JAMA Ophthalmol. 2018 Sep 1;136(9):1034-1040. doi: 10.1001/jamaophthalmol.2018.2753.
3
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.验证早产儿视网膜病变筛查标准的出生后生长和视网膜病变。
JAMA Ophthalmol. 2020 Jan 1;138(1):31-37. doi: 10.1001/jamaophthalmol.2019.4517.
4
Retrospective validation of the postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Swiss cohort.回顾性验证瑞士队列中早产儿视网膜病变(ROP)与出生后生长(G-ROP)标准的一致性。
BMC Ophthalmol. 2022 Jan 10;22(1):19. doi: 10.1186/s12886-021-02227-4.
5
Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model.费城儿童医院早产儿视网膜病变(CHOP ROP)模型的验证
JAMA Ophthalmol. 2017 Aug 1;135(8):871-877. doi: 10.1001/jamaophthalmol.2017.2295.
6
Validation of the Colorado Retinopathy of Prematurity Screening Model.科罗拉多早产儿视网膜病变筛查模型的验证
JAMA Ophthalmol. 2018 Apr 1;136(4):409-416. doi: 10.1001/jamaophthalmol.2018.0376.
7
Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort.回顾性验证日本队列中早产儿视网膜病变(ROP)及出生后生长(G-ROP)标准。
Am J Ophthalmol. 2019 Sep;205:50-53. doi: 10.1016/j.ajo.2019.03.027. Epub 2019 Apr 4.
8
Retrospective cohort evaluation of postnatal growth and retinopathy of prematurity (G-ROP) criteria in a tertiary centre in Turkey.土耳其一家三级中心的早产儿视网膜病变(ROP)后出生后生长和ROP 标准的回顾性队列评估。
Acta Ophthalmol. 2024 Aug;102(5):e712-e717. doi: 10.1111/aos.16622. Epub 2023 Dec 29.
9
Assessment of the G-ROP study criteria for predicting retinopathy of prematurity: results from a tertiary centre in Turkey.评估 G-ROP 研究标准预测早产儿视网膜病变的效果:土耳其一家三级中心的研究结果。
Int Ophthalmol. 2020 Jul;40(7):1647-1652. doi: 10.1007/s10792-020-01332-5. Epub 2020 Mar 21.
10
Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit.四级早产儿视网膜病变筛查标准在三级甲等新生儿重症监护病房中的验证和可行性。
Am J Perinatol. 2024 May;41(S 01):e2376-e2382. doi: 10.1055/a-2113-8733. Epub 2023 Jun 20.

引用本文的文献

1
Retrospective validation of the postnatal growth and retinopathy of prematurity criteria in a Chinese cohort.中国队列中早产产后生长及早产儿视网膜病变标准的回顾性验证
Front Pediatr. 2025 Jun 4;13:1509106. doi: 10.3389/fped.2025.1509106. eCollection 2025.
2
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers.中国早产儿视网膜病变筛查:一项在七个筛查中心开展的为期五年的队列研究。
BMC Ophthalmol. 2025 Jan 3;25(1):3. doi: 10.1186/s12886-024-03836-5.
3
Validation of postnatal growth and retinopathy of prematurity (G-ROP) screening guidelines in a tertiary care hospital of Pakistan: A report from low-middle income country.
巴基斯坦一家三级护理医院的新生儿生长和早产儿视网膜病变(ROP)筛查指南验证:来自中低收入国家的报告。
PLoS One. 2024 May 9;19(5):e0302534. doi: 10.1371/journal.pone.0302534. eCollection 2024.
4
Comparison of Weight-Gain-Based Prediction Models for Retinopathy of Prematurity in an Australian Population.澳大利亚人群中基于体重增加的早产儿视网膜病变预测模型的比较。
J Ophthalmol. 2023 Aug 17;2023:8406287. doi: 10.1155/2023/8406287. eCollection 2023.
5
Validation of the Postnatal Growth and Retinopathy of Prematurity (GROP) screening criteria.早产产后生长及视网膜病变(GROP)筛查标准的验证
Med Hypothesis Discov Innov Ophthalmol. 2022 Sep 23;11(2):77-84. eCollection 2022 Summer.
6
Modifiable Risk Factors and Preventative Strategies for Severe Retinopathy of Prematurity.早产儿严重视网膜病变的可改变风险因素及预防策略
Life (Basel). 2023 Apr 24;13(5):1075. doi: 10.3390/life13051075.
7
Retrospective validation of G-ROP, CO-ROP, Alex-ROP, and ROPscore predictive algorithms in two Chinese medical centers.G-ROP、CO-ROP、Alex-ROP和ROPscore预测算法在两家中国医疗中心的回顾性验证。
Front Pediatr. 2023 Feb 22;11:1079290. doi: 10.3389/fped.2023.1079290. eCollection 2023.